Investigators note that although the overall cost for implementing next-generation sequencing (NGS) testing would be more than implementing current polymerase chain reaction (PCR)–based testing, the ...
The global rapid microbiology testing market is experiencing significant growth, driven by the need for faster infection ...
New Working Group to Evaluate Clinical Utility of NGS-Based Testing to Inform Coverage After many years of steady development in DNA sequencing, the scientific community is reaching an exciting ...
While next-generation sequencing (NGS) has become routine in academic settings, its use for patients with follicular lymphoma in the community is less consistent. There are disparities in the ...
Study shows iMDx test equivalent to NGS kits for dd-cfDNA measurement in kidney transplant patients, supporting future commercialization efforts. Results from a head-to-head comparison show iMDx's ...
As next-generation sequencing (NGS) workflows increasingly rely on lower DNA and RNA inputs and greater automation, minimising sample loss has become critical. Azenta Life Sciences offers a range ...
Inherently vulnerable to viral contamination, biologics rely on animal- or human-derived starting materials and complex manufacturing processes. Albeit rare, viral contamination incidents are ...
Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...
A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results